Imunon
Clinical trials sponsored by Imunon, explained in plain language.
-
New gene therapy combo aims to boost ovarian cancer survival
Disease control Recruiting nowThis phase 3 trial tests whether adding a gene therapy called IMNN-001 (given into the abdomen) to standard chemotherapy helps people with advanced ovarian, fallopian tube, or peritoneal cancer live longer. About 500 newly diagnosed patients will be randomly assigned to receive e…
Phase: PHASE3 • Sponsor: Imunon • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
New drug combo aims to wipe out hidden ovarian cancer cells
Disease control Recruiting nowThis study tests whether adding the experimental drug IMNN-001 to standard chemotherapy and bevacizumab can better eliminate remaining cancer in people with newly diagnosed advanced ovarian, fallopian tube, or primary peritoneal cancer. About 30 participants will be randomly assi…
Phase: PHASE1, PHASE2 • Sponsor: Imunon • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC